Norway· NO-ID_358A0536-BF53-4728-81B9-1079E6A713D9

Fasigyne

A tinidazole product containing tinidazole, registered in Norway by Teofarma. The same ATC class is registered in 2 of our 19 countries.

ATC P01AB02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedFasigyneATCP01AB02REGISTER NO.NO-ID_358A0536-BF53-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Tinidazole is registered in 2 of 19 countries.

Countries holding a registration under ATC P01AB02 (tinidazole), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 2 of them publish a price we can compare per daily dose

Tinidazole · ATC P01AB02

2 / 19 countries

  • Finlandprice
  • Norwayprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Tinidazole
Manufacturer
Teofarma
Country
Norway (NO)
ATC code
P01AB02
ATC class
Tinidazole
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_358A0536-BF53-4728-81B9-1079E6A713D9
  • no_varenummer
    272910
    4
  • gtin
    3400931793823

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

183 interactions on record for tinidazole.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tinidazole · interactions on record

183 records

  • 1 severe
  • 181 moderate
  • 1 minor

Most severe, free to view

  • AmprenavirJ05AE05severe
  • LonafarnibA16AX20moderate
  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tinidazole in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tinidazole products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Bulgaria · Тинидазол Актавис
  • Cyprus · Tinirem
  • Spain · Tricolam
  • France · Fasigyne
  • Italy · Trimonase
  • Poland · Tinidazolum Polpharma
  • Romania · Tinizol, Tiprogyn

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eb7a0b6a-d545-48ba-8904-aef21802b9f8
GET /v1/drugs/eb7a0b6a-d545-48ba-8904-aef21802b9f8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Tinidazol",
  "merkevare_id": "ID_358A0536-BF53-4728-81B9-1079E6A713D9",
  "name_form_strength": "Fasigyne tab 500 mg",
  "prescription_group": "C"
}

See everything about tinidazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.